Abbott (NYSE:ABT) faces a proposed class action lawsuit related to alleged tracking tools used with its FreeStyle Libre ...

Abbott, a leader in diabetes tech with one of the biggest lines of continuous glucose monitors, announced this week that it's ...

Patients in Europe who use the FreeStyle Libre 2 Plus sensor can now team it with Insulet’s Omnipod 5 after the latter device ...

Abbott announced ... To Type 2 Diabetes Patients. This recall involves removing certain devices from where they are used or sold and does not apply to the FreeStyle Libre 3 reader or app.

Some people are facing delays in filling prescriptions for the glucose sensor. Abbott expects to resolve the problem soon.

The US Food and Drug Administration (FDA) has tagged Abbott’s recent recall of its faulty FreeStyle Libre 3 sensors as Class ...

Abbott has announced the U.S. availability of Lingo, the company’s first glucose monitoring system available without ...

Abbott Laboratories' (NYSE: ABT) business has been a bit of a roller coaster. The pandemic disrupted its medical device ...

Abbott Diabetes Care, Inc. is recalling its FreeStyle Libre 3 sensors after finding a small number of the sensors may provide incorrect high glucose readings, which, if undetected may pose ...

The iLet will soon connect to Abbott's FreeStyle Libre ® 3 Plus continuous glucose sensor, where readings every minute will help the iLet calculate insulin doses. Traditional setup and settings are ...

Thursday, Abbott Laboratories ... Glucose Monitoring To Type 2 Diabetes Patients. This recall involves removing certain devices from where they are used or sold and does not apply to the FreeStyle ...

Abbott Laboratories ... had cleared the Libre Rio, a new over-the-counter (OTC) CGM option for type 2 diabetes patients who do not use insulin (the FreeStyle Libre targets insulin and non-insulin ...